Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy

被引：8
作者：
Wen, Xue [1 ]
Qi, Lu-Ming [1 ]
Zhao, Kui [2 ]
机构：
[1] Chengdu Univ Tradit Chinese Med, Coll Hlth & Rehabil, Chengdu 610000, Sichuan, Peoples R China
[2] Southwest Forestry Univ, Coll Mat & Chem Engn, 300 White Dragon Temple, Kunming 650224, Yunnan, Peoples R China
来源：
WORLD JOURNAL OF DIABETES | 2025年 / 16卷 / 01期
关键词：
Type; 2; diabetes; Intestinal microbiome; Intestinal axis; Biological pathways; Treatment; Short-chain fatty acids; P-CRESYL SULFATE; INSULIN SENSITIVITY; INDIGENOUS BACTERIA; MICROBIOTA; MODULATION; PROBIOTICS; RECEPTOR; OBESITY;
D O I：
10.4239/wjd.v16.i1.100376
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The onset and progression of type 2 diabetes mellitus (T2DM) are strongly associated with imbalances in gut bacteria, making the gut microbiome a new potential therapeutic focus. This commentary examines the recent publication in World Journal of Diabetes. The article explores the association between T2DM and gut microbiota, with a focus on the pathophysiological changes related to dysbiosis. It proposes innovative microbiome-targeted therapeutic strategies and evaluates the challenges and future directions of such approaches. This editorial summarizes the key points of their discussion of the role of the gut microbiome in T2DM and elaborates on the influence of specific gut microbial species on the disease through the host-microbiota metabolic axis. It provides new insights for future research on gut-microbiota-based interventions for T2DM.
引用
收藏
页数：8
相关论文
共 50 条
[41]   Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes [J].
Wen, Li ;
Duffy, Andrew .
JOURNAL OF NUTRITION, 2017, 147 (07) :1468S-1475S
[42]   Dysbiosis and Regulation of Gut Microbiota in Type 2 Diabetes Mellitus [J].
Minakshi, Hemlata ;
Kumari, Hemlata ;
Prakash, Shaurya ;
Kumar, Antresh .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
[43]   Structural Aspects of Gut Peptides with Therapeutic Potential for Type 2 Diabetes [J].
Hewage, Chandralal M. ;
Venneti, Kalyana C. .
CHEMMEDCHEM, 2013, 8 (04) :560-567
[44]   Response of gut microbiota in type 2 diabetes to hypoglycemic agents [J].
Zhang, Fanghua ;
Wang, Meng ;
Yang, Junjie ;
Xu, Qian ;
Liang, Cheng ;
Chen, Bin ;
Zhang, Jiaming ;
Yang, Ying ;
Wang, Huiling ;
Shang, Yongfang ;
Wang, Ye ;
Mu, Xiaofeng ;
Zhu, Dequan ;
Zhang, Chunling ;
Yao, Minxiu ;
Zhang, Lei .
ENDOCRINE, 2019, 66 (03) :485-493
[45]   Beyond gut microbiota: understanding obesity and type 2 diabetes [J].
Lau, Eva ;
Carvalho, Davide ;
Pina-Vaz, Cidalia ;
Barbosa, Jose-Adelino ;
Freitas, Paula .
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (03) :358-369
[46]   Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes [J].
Donati Zeppa, Sabrina ;
Gervasi, Marco ;
Bartolacci, Alessia ;
Ferrini, Fabio ;
Patti, Antonino ;
Sestili, Piero ;
Stocchi, Vilberto ;
Agostini, Deborah .
NUTRIENTS, 2024, 16 (22)
[47]   Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes [J].
Caesar, Robert .
CANADIAN JOURNAL OF DIABETES, 2019, 43 (03) :224-231
[48]   Examining gut microbiota and metabolites to clarify mechanisms of Dimocarpus longan Lour leaf components against type 2 diabetes [J].
Zheng, Piao-Xue ;
Lu, Chun-Lian ;
Liang, Yan-Li ;
Ma, Yu-Ming ;
Peng, Jia-Wen ;
Xie, Jing-Jing ;
Wei, Jia-Li ;
Chen, Si-Si ;
Ma, Zhi-Dong ;
Zhu, Hua ;
Liang, Jie .
WORLD JOURNAL OF DIABETES, 2025, 16 (07)
[49]   IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans [J].
Pearson, James A. ;
Ding, Heyuan ;
Hu, Changyun ;
Peng, Jian ;
Galuppo, Brittany ;
Wong, F. Susan ;
Caprio, Sonia ;
Santoro, Nicola ;
Wen, Li .
DIABETOLOGIA, 2022, 65 (08) :1398-1411
[50]   Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes [J].
Grespan, Eleonora ;
Giorgino, Toni ;
Natali, Andrea ;
Ferrannini, Ele ;
Mari, Andrea .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 114
12345